| | Title | Author(s) | Year | View Count | | 1 |  | Telbivudine: An upcoming agent for chronic hepatitis B | Yuen, MF; Lai, CL | 2005 | 80 |
| 2 | | Liver histology of Asian patients with chronic hepatitis B on prolonged lamivudine therapy | Yuen, MF; Chow, DHF; Tsui, K; Wong, BCY; Yuen, JCH; Wong, DKH; Lai, CL | 2005 | 87 |
| 3 | | Mannose-binding lectin in chronic hepatitis B virus infection | Chong, WP; To, YF; Ip, WK; Yuen, MF; Poon, TP; Wong, WHS; Lai, CL; Lau, YL | 2005 | 99 |
| 4 | | Hepatic necroinflammation and fibrosis in patients with genotypes Ba and C, core-promoter and precore mutations | Yuen, MF; Tanaka, Y; Ng, IOL; Mizokami, M; Yuen, JCH; Wong, DKH; Yuan, HJ; Sum, SM; Chan, AOO; Lai, CL | 2005 | 111 |
| 5 | | Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism | Tanaka, Y; Orito, E; Yuen, MF; Mukaide, M; Sugauchi, F; Ito, K; Ozasa, A; Sakamoto, T; Kurbanov, F; Lai, CL; Mizokami, M | 2005 | 160 |
| 6 |  | Final Results of a Phase I/II Dose Escalation Trial of Valtorcitabine in Patients with Chronic Hepatitis B | Lim, SG; Lai, CL; Myers, M; Yuen, RMF; Wai, CT; Lloyd, D; Pietropalolo, K; Zhou, XJ; Chao, G; Brown, NA | 2005 | 131 |
| 7 | | Immune Response During Immunoclearance Phase of Chinese Patients with HBV Genotypes B and C | Yuen, RMF; Wong, DKH; Chan, CS; Zhang, Z; Yuen, JCH; Lai, CL | 2005 | 109 |
| 8 | | Treatment of chronic hepatitis B | Yuen, RMF; Lai, CL | 2005 | 62 |
| 9 | | Comparison of the COBAS TaqMan HBV Test with the COBAS Amplicor Monitor Test for Measurement of Hepatitis B Virus DNA in Serum | Sum, SM; Wong, DKH; Yuen, JCH; Lai, CL; Yuen, RMF | 2005 | 90 |
| 10 | | Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection | Yuen, MF; Wong, DKH; Sum, SSM; Yuan, HJ; Yuen, JCH; Chan, AOO; Wong, BCY; Lai, CL | 2005 | 100 |
| 11 | | Comparison of the COBAS TaqMan™ HBV test with the COBAS Amplicor Monitor™ Test for measurement of hepatitis B virus DNA in serum | Sum, SSM; Wong, DKH; Yuen, JCH; Lai, CL; Yuen, MF | 2005 | 70 |
| 12 |  | Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications | Yuen, MF; Yuan, HJ; Wong, DKH; Yuen, JCH; Wong, WM; Chan, AOO; Wong, BCY; Lai, KC; Lai, CL | 2005 | 347 |
| 13 | | Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong | Yuen, MF; Sablon, E; Tanaka, Y; Kato, T; Mizokami, M; Doutreloigne, J; Yuan, HJ; Wong, DKH; Sum, SM; Lai, CL | 2004 | 104 |
| 14 | | SARS-Associated Viral Hepatitis Caused by a Novel Coronavirus: Report of Three Cases | Chau, TN; Lee, KC; Yao, H; Tsang, TY; Chow, TC; Yeung, YC; Choi, KW; Tso, YK; Lau, T; Lai, ST; Lai, CL | 2004 | 77 |
| 15 | | Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: A protocol with early elimination of steroids and reduction of tacrolimus dosage | Liu, CL; Fan, ST; Lo, CM; Chan, SC; Ng, IO; Lai, CL; Wong, J | 2004 | 119 |
| 16 | | HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects | Yuen, MF; Wong, DKH; Sablon, E; Tse, E; Ng, IOL; Yuan, HJ; Siu, CW; Sander, TJ; Bourne, EJ; Hall, JG; Condreay, LD; Lai, CL | 2004 | 125 |
| 17 | | Therapeutic advances in chronic hepatitis B | Lai, CL | 2004 | 68 |
| 18 | | 18-Year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children | Yuen, MF; Lim, WL; Chan, AOO; Wong, DKH; Sum, SSM; Lai, CL | 2004 | 219 |
| 19 | | Practical Difficulties in the Management of Hepatitis B in the Asia-Pacific Region | Mohamed, R; Desmond, P; Suh, DJ; Amarapurkar, D; Gane, E; Guangbi, Y; Hou, JL; Jafri, W; Lai, CL; Lee, CH; Lee, SD; Lim, SG; Guan, R; Phiet, PH; Piratvisuth, T; Sollano, J; Wu, JC | 2004 | 115 |
| 20 | | Adefovir dipivoxil in chronic hepatitis B infection | Yuen, MF; Lai, CL | 2004 | 90 |
|
